AstraZeneca PLC (AZN)
77.20
-0.41
(-0.53%)
USD |
NASDAQ |
May 10, 16:00
77.20
0.00 (0.00%)
After-Hours: 18:43
AstraZeneca Gross Profit (Quarterly): 10.46B for March 31, 2024
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 10.46B |
December 31, 2023 | 9.716B |
September 30, 2023 | 9.397B |
June 30, 2023 | 9.456B |
March 31, 2023 | 8.974B |
December 31, 2022 | 8.307B |
September 30, 2022 | 8.00B |
June 30, 2022 | 7.773B |
March 31, 2022 | 7.879B |
December 31, 2021 | 7.386B |
September 30, 2021 | 6.109B |
June 30, 2021 | 6.029B |
March 31, 2021 | 5.456B |
December 31, 2020 | 5.885B |
September 30, 2020 | 5.208B |
June 30, 2020 | 5.291B |
March 31, 2020 | 4.934B |
December 31, 2019 | 5.286B |
September 30, 2019 | 5.055B |
June 30, 2019 | 4.76B |
March 31, 2019 | 4.362B |
December 31, 2018 | 4.78B |
September 30, 2018 | 4.187B |
June 30, 2018 | 4.143B |
March 31, 2018 | 4.044B |
Date | Value |
---|---|
December 31, 2017 | 4.552B |
September 30, 2017 | 4.983B |
June 30, 2017 | 4.101B |
March 31, 2017 | 4.511B |
December 31, 2016 | 4.425B |
September 30, 2016 | 4.799B |
June 30, 2016 | 4.541B |
March 31, 2016 | 5.111B |
December 31, 2015 | 5.13B |
September 30, 2015 | 4.904B |
June 30, 2015 | 5.24B |
March 31, 2015 | 4.788B |
December 31, 2014 | 5.049B |
September 30, 2014 | 5.194B |
June 30, 2014 | 5.455B |
March 31, 2014 | 5.007B |
December 31, 2013 | 5.499B |
September 30, 2013 | 5.012B |
June 30, 2013 | 4.915B |
March 31, 2013 | 5.119B |
December 31, 2012 | 5.884B |
September 30, 2012 | 5.408B |
June 30, 2012 | 5.314B |
March 31, 2012 | 5.974B |
December 31, 2011 | 7.044B |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
4.76B
Minimum
Jun 2019
10.46B
Maximum
Mar 2024
7.068B
Average
6.748B
Median
Gross Profit (Quarterly) Benchmarks
GSK PLC | 6.840B |
Amgen Inc | 4.247B |
Sanofi SA | 8.341B |
Viking Therapeutics Inc | -- |
Fusion Pharmaceuticals Inc | -- |